StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Anixa Biosciences (ANIX)

Anixa receives Canadian patent allowance for ovarian cancer vaccine June 1, 2026 9:00 AM - StreetInsider Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance June 1, 2026 9:00 AM - PR NewsWire /C O R R E C T I O N -- Anixa Biosciences, Inc./ May 11, 2026 11:48 AM - PR NewsWire Anixa Biosciences reports patient survival data from cancer therapy trial May 11, 2026 8:55 AM - StreetInsider Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy May 11, 2026 8:55 AM - PR NewsWire Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV May 1, 2026 9:15 AM - PR NewsWire Anixia Biosciences and OwlTing Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV May 1, 2026 9:00 AM - StreetInsider Anixa Biosciences receives Mexican patent for breast cancer vaccine April 29, 2026 9:10 AM - StreetInsider Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology April 29, 2026 9:10 AM - PR NewsWire Anixa Biosciences ovarian cancer therapy to be presented at gene therapy meeting April 22, 2026 8:45 AM - StreetInsider Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting April 22, 2026 8:45 AM - PR NewsWire RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation April 10, 2026 12:56 PM - StreetInsider Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 April 9, 2026 9:05 AM - PR NewsWire Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 April 7, 2026 12:50 PM - PR NewsWire Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs April 6, 2026 9:10 AM - PR NewsWire Anixa Biosciences partners with Cytovance for breast cancer vaccine Phase 2 April 1, 2026 8:50 AM - StreetInsider Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing April 1, 2026 8:50 AM - PR NewsWire Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer March 30, 2026 9:05 AM - PR NewsWire Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast March 12, 2026 10:39 AM - PR NewsWire Form 8-K Anixa Biosciences Inc For: Mar 10 March 11, 2026 5:04 PM - SEC Filing Full Article List